How We Deliberately Reduce Avoidable Risk

  • IP: Six interlocking systems prepared for U.S. utility filings.
     

  • Capital: The US $15M Milestone Equity Facility activates only after patent filings, protecting capital from premature deployment.
     

  • Execution: Pre-sequenced 18-month build, top-tier hiring via retained search, CFO oversight.
     

  • Model: We minimize adoption friction — users keep familiar behaviors; our trust and incentive layer changes outcomes under the hood. There is still execution and adoption risk, but the path is designed to avoid ‘new toy’ fatigue.

Two Capital Tracks — One Ignition Window

Plethora’s capital structure operates in two coordinated lanes: a fixed US$750K Sponsor Pool to validate the patent strategy and prepare the U.S. operating structure, and a US$15M Milestone Equity Facility that funds the 18–24 month full build once filings begin. The broader facility provides up to US$60M total capacity, drawn only as needed.

SPONSOR ROUND

(Patent Validation & Structuring — US$750K)

Purpose: 
Validate the patent path, confirm claim strategy, and prepare the U.S. operating structure before any patent filings occur.

 

Use: 
Deployed in two defined phases within the fixed US$750K Sponsor Pool:

  • Phase A — US$250K total
     – First US$50K funds formal prior-art and claim validation with U.S. patent counsel.
     – The remaining US$200K is released after strategy confirmation and funds U.S. entity setup, legal structuring, and operational readiness.
     – No patent filings occur in Phase A.
  • Phase B — US$500K
     – Drawn only after the US$15M Milestone Equity Facility is fully committed.
     – Funds full U.S. utility filings and synchronized build ignition. 

Terms:

  • Instrument: Structured sponsor loan with equity kicker (final form documented individually with counsel); 1% pooled equity in future U.S. operating company

  • Enhanced early tranche (Phase A): Phase A sponsor capital (US$250K total) receives 2x total payback upon Milestone Equity Facility activation.

  • Standard tranche (Phase B): Sponsor capital completes structural preparation and enables coordinated patent filing upon Milestone Facility activation.

  • 1% pooled equity in the U.S. operating company once formed, shared pro-rata across all sponsors, with a larger share allocated to Phase A sponsors

  • Sponsor capital completes the capital lock and unlocks patent filing and the 18-month stealth window

  • Sponsor loan is reimbursed from the first US $15M activation allocation immediately after filings and institutional funding

  • Structured liquidity program eligibility after defined performance thresholds: Once Plethora reaches US $100M cumulative PTCFF, sponsors may elect to sell their position back to the company at a target 10x multiple on principal, subject to board approval and available capital

  • Founding Circle status

  • Priority access into equity facility allocations and future strategic opportunities

Capital Tiers — One Raise, Two Positions

All equity sits inside a single structured facility. The first US$15M milestone capital funds the 18–24 month build; the remaining capacity (up to US$60M total) supports scale once traction is validated. Entry timing defines allocation and strategic positioning.

FOUNDING TIER

(First $15M Only)

Unlocks additional advantages — available only to earliest committed capital.

 

Entry Closes: Permanently at US $15M

Purpose: Secures the execution runway — capital is released immediately upon patent filing and stealth entry.

 

Additional Privileges:

  • Founding Equity Investor Status

  • Pro-rata equity share within the 30% fully-diluted pool of the U.S. operating company

  • Priority access to ecosystem deals

  • Quarterly strategic briefings with the Founder

  • Defined strategic role in ecosystem decisions (without day-to-day governance control)

  • Preferred allocation in any structured liquidity programs

BASELINE

(Applies to all $60M raise participants — including Founding Tier)

Purpose: Scale, expand, win the category

All investors in the US $60M raise receive:

  • Pro-rata equity share in a 30% fully-diluted pool of the U.S. operating company

  • Structured liquidity program eligibility after defined performance thresholds: Once Plethora reaches US $3B cumulative PTFCF, eligible equity investors may elect to participate in a structured liquidity program targeting up to 10x on principal, subject to final terms, board approval, and available capital

  • Preferred position in any structured liquidity events, subject to final terms

  • Financial transparency (CFO-led reporting)

  • Founder-led governance protection (information rights, no voting control)

  • Access to long-term strategic opportunities

     

Stealth Window: Patent filing initiates Plethora’s 18-month stealth execution window — a legally protected period during which core systems are built without market exposure or replication risk. Investors who commit prior to filing are positioned ahead of external visibility, valuation pressure, and institutional pricing dynamics — securing access before the protocol seals.

PTFCF: (Post-Tax Free Cash Flow) refers to Plethora’s cumulative net earnings after all internal givebacks, obligations and corporate taxes. It represents clean, unencumbered capital, and serves as the internal benchmark for investor exit optionality — ensuring a transparent, performance-driven return framework aligned with long-term sustainability.

Why Act Now 

  1. This is the institutional entry point before patent filings trigger Plethora’s 18-month stealth execution window — when the core systems are built away from competitive visibility.

     

  2. The first US$15M milestone capital funds the defined 18–24 month execution window. Additional capacity (up to US$60M total) supports scale once performance is demonstrated.

     

  3. Investors who commit before filing anchor the cap table and long-term economics before valuation pressure, late-stage capital, and public visibility enter the picture.

Choose your entry point into Plethora’s future.

This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Any investment will be made only pursuant to formal legal documentation and in compliance with applicable securities laws. Plethora™ is an emerging digital infrastructure project developed and governed through Titanforge, a Québec-registered independent R&D company (9464-9209 Québec inc., doing business as Titanforge). All intellectual property, structural designs, and related work are assigned through formal agreements and will transition to the U.S. operating entity upon corporate structuring.

 

Ce site est présenté en anglais.

Pour toute question juridique ou administrative en français, veuillez écrire à : legal[@]titanforge[point]co

Overview → What It Is →Funding Path →Contact →
Titanforge →Robert Parent →Positive Sum Society →
Investor Brief → Sponsor Overview → Development Milestones →
Terms & Conditions →Privacy Policy →Use of Information →